Surrozen, Inc./DE financial data

Symbol
SRZN, SRZNW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
171 Oyster Point Blvd, Suite 400, South San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Consonance-HFW Acquisition Corp. (to 8/11/2021)
Latest financial report
10-Q - Q2 2024 - Aug 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 628 % -29%
Debt-to-equity 52 % +197%
Return On Equity -179 % -221%
Return On Assets -118 % -148%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.21M shares -89.5%
Common Stock, Shares, Outstanding 3.21M shares -89.5%
Entity Public Float 11.5M USD -84.9%
Common Stock, Value, Issued 0 USD -100%
Weighted Average Number of Shares Outstanding, Basic 3.16M shares +57.8%
Weighted Average Number of Shares Outstanding, Diluted 3.16M shares +57.8%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 22.8M USD -31.1%
General and Administrative Expense 14.8M USD -21.7%
Operating Income (Loss) -39.1M USD +3.81%
Net Income (Loss) Attributable to Parent -53.4M USD -41.3%
Earnings Per Share, Basic -21.7 USD/shares +18.9%
Earnings Per Share, Diluted -21.7 USD/shares +18.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 37.8M USD +3.48%
Marketable Securities, Current 0 USD -100%
Cash, Cash Equivalents, and Short-term Investments 27.3M USD -55.8%
Accounts Receivable, after Allowance for Credit Loss, Current 2.11M USD +6.78%
Assets, Current 41.6M USD -27.7%
Property, Plant and Equipment, Net 1.2M USD -59.6%
Operating Lease, Right-of-Use Asset 1.18M USD -55.7%
Other Assets, Noncurrent 373K USD -5.33%
Assets 45.1M USD -29.6%
Accounts Payable, Current 173K USD -6.99%
Accrued Liabilities, Current 3.64M USD -6.59%
Liabilities, Current 5.98M USD -7.26%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 39M USD +336%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -256M USD -26.4%
Stockholders' Equity Attributable to Parent 6.06M USD -89%
Liabilities and Equity 45.1M USD -29.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.75M USD +38.3%
Net Cash Provided by (Used in) Financing Activities 0 USD
Net Cash Provided by (Used in) Investing Activities 17.3M USD
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 3.21M shares -89.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -8.75M USD -381%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 38.5M USD +4.21%
Deferred Tax Assets, Valuation Allowance 54M USD +19%
Deferred Tax Assets, Gross 54.4M USD +18%
Operating Lease, Liability 2.17M USD -52.2%
Payments to Acquire Property, Plant, and Equipment 7K USD -97.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -53.5M USD -43.2%
Lessee, Operating Lease, Liability, to be Paid 2.24M USD -54.1%
Property, Plant and Equipment, Gross 9.34M USD -37.7%
Operating Lease, Liability, Current 2.17M USD -8.38%
Lessee, Operating Lease, Liability, to be Paid, Year Two 891K USD -66.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 891K USD -66.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 69K USD -79.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 891K USD -66.6%
Deferred Tax Assets, Operating Loss Carryforwards 36.4M USD +10.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 1.73M USD +5.96%
Additional Paid in Capital 262M USD +1.73%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 449K USD -42.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%